Lilly is committed to advancing innovative science to enable a better approach to comprehensive pain management for people living with unresolved pain.
For people living with unresolved pain, it’s more than just physical. The consequences can permeate one’s entire life. The ability to function, the capacity to work, the opportunity to live with dignity. All can be compromised.
We believe pain should not define someone’s life. We believe we must do better.
At Lilly, we are sparking a new conversation about unresolved pain. A conversation that challenges us to tackle the uniquely complex scientific and societal challenges of recurrent and chronic pain, including migraine, episodic cluster headache and osteoarthritis pain. To do so, we are committed to advancing the innovative science, policies and non-opioid medicines needed to reshape and enable a better approach to comprehensive pain management and treatment outcomes.
Information placed on this website is not intended as a substitute for consultation with your healthcare professional.